HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

ALCHEMIST <span style="font-weight:normal"><i>(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)</i></span>: Questions and Answers

treatment  trial  drug  screening  lung  tumor  genetic  gene  marker  mutation  ALK  EGFR  survival  ALCHEMIST 

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

Preview   0 Users liked this content.
CDC

Preventing Chronic Disease | Native American Race, Use of the Indian Health Service, and Breast and Lung Cancer Survival in Florida, 1996-2007 - CDC

CDC  indians  survival  Native Americans  Preventing Chronic Disease  PCD  health care disparities  breast neoplasms  lung diseases  Indian Health Service 

We evaluated associations of race, primary payer at diagnosis, and survival among patients diagnosed in Florida with lung cancer (n = 148,140) and breast cancer (n = 111,795), from 1996 through 2007. In multivariate models adjusted for comorbidities, tumor characteristics, and treatment factors, breast cancer survival was worse for Native American women than for white women (hazard ratio [HR], 1.52; 95% confidence interval [CI], 1.05–2.20) and for women using the Indian Health Service than for women using private insurance (HR, 1.71; 95% CI, 1.33–2.19). No survival association was found for Native American compared with white lung cancer patients or those using the Indian Health Service versus private insurance in fully adjusted models. Additional resources are needed to improve surveillance strategies and to reduce cancer burden in these populations.

Preview   0 Users liked this content.
NCI

Hormone Replacement Therapy May Improve Survival for Women with Ovarian Cancer

HRT  hormone therapy  estrogen  ovarian cancer  hormone replacement therapy  postmenopausal symptoms  survival  institute for cancer research  adjuvant therapy  women’s health initiative  womens health initiative 

The randomized, controlled Adjuvant Hormone Therapy trial was launched in 1990 to assess the effects of estrogen-alone hormone replacement therapy in women treated for epithelial ovarian cancer.

Preview   0 Users liked this content.